Brief: Hamlet Pharma Q1 Loss Before Tax Narrows To SEK 2.7 Mln
08/11/2019 08:05
Nov 8 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* Q1 LOSS BEFORE TAX AMOUNTED TO SEK 2.7 MILLION VERSUS LOSS
SEK
3.0 MILLION YEAR AGO
Source text for Eikon: ID:nWkr2tSVXH
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe